trial · primary record
Staccato alprazolam
Stereotypical Prolonged Seizures
| Phase | Phase 3 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 350 |
| Primary completion | 2027-03-29 |
| Primary endpoint | Treatment success for the treated seizure within 90 seconds after investigational medicinal product (IMP) administration |
| Registry ID | NCT05077904 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T02:31:39.232Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT05077904
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.